Details for Patent: 8,357,394

Which drugs does patent 8,357,394 protect, and when does it expire?

Patent 8,357,394 protects MOXATAG and is included in one NDA.

This patent has eleven patent family members in six countries.

Summary for Patent: 8,357,394

Title:	Compositions and methods for improved efficacy of penicillin-type antibiotics
Abstract:	Disclosed are once-a-day penicillin-type antibiotic products comprising at least one modified release dosage form comprising penicillin-type antibiotics and pharmaceutically acceptable carriers, which compositions provide T>MIC.sub.90 in the serum for at least 5 hours (preferably for at least five consecutive hours), within a 24-hour dosing interval, for a given bacterial pathogen's MIC.sub.90, while providing a total dosage of the penicillin-type antibiotic for a 24-hour dosing interval.
Inventor(s):	Flanner; Henry H. (Montgomery Village, MD), Guttendorf; Robert J. (Gaitherburg, MD), Clausen; Susan P. (Ijamsville, MD), Treacy; Donald (Woodbine, MD), Burnside; Beth A. (Bethesda, MD)
Assignee:	Shionogi Inc. (Florham Park, NJ)
Application Number:	11/636,291
Patent Claim Types: see list of patent claims	Composition; Compound; Dosage form;

Drugs Protected by US Patent 8,357,394

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Pragma	MOXATAG	amoxicillin	TABLET, EXTENDED RELEASE;ORAL	050813-001	Jan 23, 2008		DISCN	Yes	No			Y

International Family Members for US Patent 8,357,394

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2006321782
Australia	2006351475
Canada	2635378
Canada	2635606
China	101563466
European Patent Office	1968586
European Patent Office	1969134